Asia Pacific Academy of Science Pte. Ltd. (APACSCI) specializes in international journal publishing. APACSCI adopts the open access publishing model and provides an important communication bridge for academic groups whose interest fields include engineering, technology, medicine, computer, mathematics, agriculture and forestry, and environment.
Omega-3 fatty acids have little or no cardiovascular protection: An interventional study
Vol 3, Issue 2, 2022
Issue release: 31 December 2022
VIEWS - 3787 (Abstract)
Download PDF
Abstract
Background: There is a great deal of public belief in the cardiovascular benefits of omega-3 fats. Recent trials on the effects of omega-3 fatty acids in cardiovascular issues are unclear or have failed to demonstrate significant benefits in reducing cardiovascular events. The current study aims to perform a human trial using omega-3 fatty acids as a supplementation to test its effectiveness on cardiovascular diseases. Methods: A randomized interventional study was carried out in 145 patients in the age group of 18 or older at any risk of cardiovascular disease. A treatment period of 6 months with supplementation of daily dose of 360 mg of EPA and 480 mg of DHA for one group and to the other group, atorvastatin 10 mg were given. Biochemical and clinical evaluations were performed for the baseline, 3rd and the 6th months to assess the effectiveness of omega-3 fatty acids on cardiovascular diseases. Results: The changes in the biochemical parameters total cholesterol, High density lipoprotein (HDL), Low density lipoprotein (LDL), and triglycerides among the omega-3 fatty acid group and statin group were as 218.17 vs 204.45, 55.24 vs 60.3, 142.9 vs 132.41and 168.95 vs 152.5, respectively with a p value of 0.0001. Omega-3 supplements were shown to have little to no effect on the risk of cardiovascular diseases according to the research. Conclusion: The better evidence identified in this research does not demonstrate any cardiovascular protection with the supplementation of omega-3 fats.
Keywords
References
1. World Health Organization. Cardiovascular Diseases (CVDs). Available online: www.who.int/mediacentre/factsheets/fs317/en (accessed on 24 November 2017).
2. Li D, Sinclair A, Wilson A, et al. Effect of dietary alpha-linolenic acid on thrombotic risk factors in vegetarian men. The American Journal of Clinical Nutrition. 1999; 69(5): 872-882. doi: 10.1093/ajcn/69.5.872
3. Pawlosky RJ, Hibbeln JR, Novotny JA, et al. Physiological compartmental analysis of alpha-linolenic acid metabolism in adult humans. Journal of Lipid Research. 2001; 42: 1257-1265.
4. Bhatnagar D, Durrington PN. Omega-3 fatty acids: Their role in the prevention and treatment of atherosclerosis related risk factors and complications. International Journal of Clinical Practice. 2003; 57(4): 305-314. doi: 10.1111/j.1742-1241.2003.tb10490.x
5. British Nutrition Foundation. N-3 fatty acids and health. London: British Nutrition Foundation; 1999.
6. Calabresi L, Villa B, Canavesi M, et al. An omega-3 polyunsaturated fatty acid concentrate increases plasma high-density lipoprotein 2 cholesterol and paraoxonase levels in patients with familial combined hyperlipidemia. Metabolism. 2004; 53(2): 153-158. doi: 10.1016/j.metabol.2003.09.007
7. Chang CL, Deckelbaum RJ. Omega-3 fatty acids: Mechanisms underlying “protective effects” in atherosclerosis. Current Opinion in Lipidology. 2013; 24(4): 345-350. doi: 10.1097/mol.0b013e3283616364
8. Geelen A, Brouwer IA, Zock PL, et al. Antiarrhythmic effects of n-3 fatty acids: evidence from human studies. Current Opinion in Lipidology. 2004; 15(1): 25-30. doi: 10.1097/00041433-200402000-00006
9. Papanikolaou Y, Brooks J, Reider C, et al. U.S. adults are not meeting recommended levels for fish and omega-3 fatty acid intake: results of an analysis using observational data from Nhanes 2003-2008. Nutrition Journal. 2014; 13(1). doi: 10.1186/1475-2891-13-31
10. Nice. Cardiovascular disease: Risk assessment and reduction, including lipid modification clinical guideline; 2014. Available online: www.nice.org.uk/guidance/cg181 (accessed on 12 March 2020).
11. Ballard-Barbash R, Callaway CW. Marine fish oils: Role in prevention of coronary artery disease. Mayo Clinic Proceedings 1987; 62: 113-118.
12. Burr ML. Fish and ischemic heart disease. World Review of Nutrition Diet. 1993; 72: 49-60. doi: 10.1159/000422327
13. Kris-Etherton PM, Harris WS, Appel LJ. Fish consumption, fish oil, omega 3 fatty acids, and cardiovascular disease. Circulation. 2002; 106(21): 2747-2757. doi: 10.1161/01.cir.0000038493.65177.94
14. Campbell A, Price J, Hiatt WR. Omega-3 fatty acids for intermittent claudication. Cochrane Database of Systematic Reviews. 2013; 7. doi: 10.1002/ 14651858.CD003833.pub4
15. He Z, Yang L, Tian J, et al. Efficacy and safety of omega-3 fatty acids for the prevention of atrial fibrillation: A meta-analysis. Canadian Journal of Cardiology. 2013; 29: 196-203. doi: 10.1016/j.cjca.2012.03.019
16. Zhao Y, Chen Q, Sun Y, et al. Prevention of sudden cardiac death with omega-3 fatty acids in patients with coronary heart disease: A meta-analysis of randomized controlled trials. Ann Med. 2009; 41: 301-310. doi: 10.1080/07853890802698834
17. Trikalinos TA, Moorthy D, Chung M, et al. Concordance of randomized and nonrandomized studies was unrelated to translational patterns of two nutrient-disease associations. Journal of Clinical Epidemiology. 2012; 65(1): 16-29. doi: 10.1016/j.jclinepi.2011.07.006
18. Sethi A, Bajaj A, Khosla S, et al. Statin use mitigate the benefit of omega-3 fatty acids supplementation: a meta-regression of randomized trials. American Journal of Therapeutics. 2016; 23(3): e737-e748. doi: 10.1097/mjt.0000000000000048
19. Larsson SC, Orsini N, Wolk A. Long-chain omega-3 polyunsaturated fatty acids and risk of stroke: A metaanalysis. European Journal of Epidemiology. 2012; 27(12): 895-901. doi: 10.1007/s10654-012-9748-9
Refbacks
- There are currently no refbacks.
Copyright (c) 2022 Ramaiyan Velmurugan, DS. Harshini Yaamika
This work is licensed under a Creative Commons Attribution 4.0 International License.
This site is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).
Prof. Prakash Deedwania
University of California,
San Francisco, United States
